June 4-7, 2018 | Boston, MA

BIO Exhibition 

Double Helix Sponsor


Schedule at a glance

Registration Rates

Join the Mailing List

Start-Up Stadium
Print Schedule

Empowering the Cutting-Edge Companies of Tomorrow, Today

Start Up Stadium LogoAs the world’s largest biotechnology event, the BIO International Convention provides several specialized opportunities geared towards start-up and emerging companies. The Start-Up Stadium was designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, and BIO attendees. This area in the BIO Exhibition provides an exciting and interactive experience where investors provide live feedback and judge 6 minute pitches presented by start-up biotech companies.



 2018 Judges    2018 Investor & Subcommittee    


2018 BIO Convention Participants


 AcuraStem Inc. 

 Airware, Inc. dba Glucoware 


 BioAesthetics Corporation 

 BioHybrid Solutions LLC 

 Cabin Labs LLC 

 Casterbridge Pharmaceuticals I 


 Celldom, Inc 


 Context Therapeutics 

 Cytosolix, Inc. 

 Encompass Bioscience 

 Falcon Therapeutics 

 FIMECS, Inc. 

 Fluid-Screen, Inc. 

 Genomic Expression 

 GreenMark Biomedical Inc. 


 Lauren Sciences LLC 

 Lipid Biologics, LLC 

 Lumme Inc  

 MagGenome Technologies Pvt. Lt 


 Mekanistic Therapeutics 

 Mikro Biyosistemler 

 Mirata BioPharma 

 Moleculera Labs 

 Monarch Biosciences, Inc. 

 OcuMedics, Inc. 

 Open Therapeutics 

 OXT Therapeutics 



 Regenerative Medical Services  


 Scaled Biolabs Inc. 

 SFA Therapeutics 

 Shifa Biomedical Corporation  

 Signia Therapeutics 

 Sixal Inc. 

 Strand Therapeutics 


 WeMED Bio-Tech Inc.

Thank You to Our 2018 Start-Up Stadium Sponsors! 

Mintz Levin Logo VWR new MassChallenge

2017 Start Up Stadium Image

BIO had 40 finalists for its third annual Start-Up Stadium event, taking place at the BIO International Convention from June 19th-22nd in San Diego, CA. In 2017, applications were submitted from coast to coast across the United States and countries around the world. The finalists, whose sole purpose is to develop cutting-edge technologies and therapeutic solutions while becoming commercially viable, span 14 U.S. states and the globe – with representation from biotech and pharma hotbed countries such as Canada, Germany, and India.

Applications were judged by experts with entrepreneurial, investment, start-up, economic development, capital formation, and academic backgrounds from both the public and private sectors. The first panel of judges reviewed over 100 applications in order to establish the current pool of 40+ highly-qualified finalists. The second panel will be evaluating the finalists’ during live presentations at the BIO International Convention.




Phone: +

Thank you to our 2018 Sponsors

Double Helix Sponsors

Helix Sponsors

Premier Sponsors